DIFFERENTIAL REGULATION OF LUTEINIZING-HORMONE, FOLLICLE-STIMULATING-HORMONE, AND FREE ALPHA-SUBUNIT SECRETION FROM THE GONADOTROPE BY GONADOTROPIN-RELEASING HORMONE (GNRH) - EVIDENCE FROM THE USE OF 2 GNRH ANTAGONISTS

被引:68
作者
HALL, JE
WHITCOMB, RW
RIVIER, JE
VALE, WW
CROWLEY, WF
机构
[1] MASSACHUSETTS GEN HOSP, DEPT MED, BOSTON, MA 02114 USA
[2] MASSACHUSETTS GEN HOSP, DEPT GYNECOL, BOSTON, MA 02114 USA
[3] SALK INST BIOL STUDIES, LA JOLLA, CA 92037 USA
关键词
D O I
10.1210/jcem-70-2-328
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To examine the differential regulation of glycoprotein hormone secretion from the gonadotrope by GnRH, the Nal-Glu GnRH antagonist was administered to euthyroid women in the early follicular phase (days 1–5) of the menstrual cycle, and the results compared to previous studies with the Nal- Arg GnRH antagonist. After a 4-h period of baseline sampling at a frequency of every 10 min, a single sc dose of the GnRH antagonist was administered to each subject. Frequent sampling continued for 8 h, followed by hourly sampling for a further 16 h. LH, FSH, and free α-subunit were measured serially in assays with high specificity. There was a 90% concordance of LH and free α-subunit pulses during the baseline sampling period. Pulsatile secretion of LH and free α-subunit was immediately abolished at the highest dose of the Nal-Glu antagonist for at least 8 h. The maximum percent suppression of LH after administration of the Nal-Glu GnRH antagonist was 70 ± 4%, 80 ± 4%, and 83 ± 1% at doses of 15, 50, and 150 μg/kg, respectively, compared to 51 ± 10%, 70 ± 5%, and 69 ± 5% at doses of 50, 150, and 500 μg/kg Nal-Arg antagonist. Decreases in FSH were 28 ± 2%, 32 ± 7%, and 39 ± 2%, with increasing doses of the Nal-Glu antagonist compared with 25 ± 6%, 17 ± 6%, and 28 ± 4% reductions at increasing doses of the Nal-Arg antagonist. Free α-subunit decreased 22 ± 4%, 23 ± 4%, and 28 ± 3% at increasing doses of the Nal-Glu antagonist and 12 ± 4%, 27 ± 4%, and 30 ± 7% with increasing doses of the Nal-Arg antagonist. For the Nal- Glu antagonist, suppression of LH was greater than that of FSH and free α-subunit at all doses (P < 0.001), while FSH suppression was greater than that of free α-subunit at the highest dose only (P < 0.05). For the Nal-Arg antagonist, LH suppression was greater than that of FSH or free α-subunit at all doses (P > 0.01), and FSH suppression exceeded that of free α-subunit at the 50 μg/kg dose. Suppression of LH was greater with the Nal-Glu antagonist than with the Nal-Arg antagonist at doses of 50 and 150 μg/kg (P < 0.05), and FSH suppression was greater with the Nal-Glu antagonist at 150 μg/kg (P < 0.01), while the degrees of maximum suppression were similar for the two different GnRH antagonists for free α-subunit. We conclude that 1) GnRH receptor blockade eradicates the pulsatile nature of both LH and free α-subunit secretion; 2) GnRH antagonism differentially suppresses LH, FSH, and free α-subunit, suggesting differential regulation of these three hormones, which are secreted from the gonadotrope in response to GnRH; and 3) the Nal-Glu antagonist is a more potent GnRH antagonist than the Nal-Arg antagonist in this model. © 1990 by The Endocrine Society.
引用
收藏
页码:328 / 335
页数:8
相关论文
共 25 条
[1]  
CORBIN A, 1975, ENDOCR RES COMMUN, V2, P1
[2]  
Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473
[3]   THE BIOLOGIC ACTIVITY OF A POTENT ANALOG OF GONADOTROPIN-RELEASING HORMONE IN NORMAL AND HYPOGONADOTROPIC MEN [J].
CROWLEY, WF ;
BEITINS, IZ ;
VALE, W ;
KLIMAN, B ;
RIVIER, J ;
RIVIER, C ;
MCARTHUR, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (19) :1052-1057
[4]   EVIDENCE THAT PULSATILE FOLLICLE-STIMULATING-HORMONE SECRETION IS INDEPENDENT OF ENDOGENOUS LUTEINIZING-HORMONE-RELEASING HORMONE [J].
CULLER, MD ;
NEGROVILAR, A .
ENDOCRINOLOGY, 1986, 118 (02) :609-612
[5]   PULSATILE FOLLICLE-STIMULATING-HORMONE SECRETION IS INDEPENDENT OF LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH) - PULSATILE REPLACEMENT OF LHRH BIOACTIVITY IN LHRH-IMMUNONEUTRALIZED RATS [J].
CULLER, MD ;
NEGROVILAR, A .
ENDOCRINOLOGY, 1987, 120 (05) :2011-2021
[6]  
DAHL KD, 1986, J CLIN ENDOCR METAB, V63, P792
[7]   CHARACTERIZATION OF THE PHYSIOLOGICAL PATTERN OF EPISODIC GONADOTROPIN-SECRETION THROUGHOUT THE HUMAN MENSTRUAL-CYCLE [J].
FILICORI, M ;
SANTORO, N ;
MERRIAM, GR ;
CROWLEY, WF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (06) :1136-1144
[8]   DIFFERENTIAL SUPPRESSION OF FOLLICLE-STIMULATING-HORMONE AND LUTEINIZING-HORMONE SECRETION INVIVO BY A GONADOTROPIN-RELEASING HORMONE ANTAGONIST [J].
GRADY, RR ;
SHIN, L ;
CHARLESWORTH, MC ;
COHENBECKER, IR ;
SMITH, M ;
RIVIER, C ;
RIVIER, J ;
VALE, W ;
SCHWARTZ, NB .
NEUROENDOCRINOLOGY, 1985, 40 (03) :246-252
[9]   PULSATILE SECRETION OF THYROTROPIN IN MAN [J].
GREENSPAN, SL ;
KLIBANSKI, A ;
SCHOENFELD, D ;
RIDGWAY, EC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (03) :661-668
[10]   EVIDENCE OF DIFFERENTIAL CONTROL OF FSH AND LH-SECRETION BY GONADOTROPIN-RELEASING HORMONE (GNRH) FROM THE USE OF A GNRH ANTAGONIST [J].
HALL, JE ;
BRODIE, TD ;
BADGER, TM ;
RIVIER, J ;
VALE, W ;
CONN, PM ;
SCHOENFELD, D ;
CROWLEY, WF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (03) :524-531